Abstract: A method, system and computer program product for determining changes in breast density. A generative adversarial network is trained to predict an appearance of a mammogram image for a patient's current examination based on mammogram images assigned labels of a first type of density classification. An appearance of a mammogram image for a patient's current examination is predicted using the generative adversarial network based on a mammogram image(s) obtained from the patient's prior examination assigned labels of the first type of density classification. A comparison is made between the predicted and actual mammogram images for the patient's current examination to determine if there is a difference between scores assigned to the predicted and actual mammogram images, and if so, whether such difference can be attributed to the subjective assessment by different physicians or changes in the standards of density classification or is due to a real change in breast density.

Abstract: Disclosed are methods of forming a multiple coating on a dry plating member and a molded article manufactured using the same. The method may include applying a color coating agent onto a surface of a plating layer of a plating member and then drying the applied color coating agent to form a color coating layer, and applying a clear coating agent onto a surface of the color coating layer and curing the applied clear coating agent to form a clear layer, wherein the plating member includes a substrate, an undercoat layer formed on a surface of at least a part of the substrate, and a plating layer formed on a surface of the undercoat layer.

Abstract: A method of manufacturing a multiple-color plating member includes forming a copper plating layer on at least a part of a surface of a substrate, forming a nickel plating layer on a surface of the copper plating layer, forming a chromium plating layer on a surface of the nickel plating layer, applying a color coating agent onto a surface of the chromium plating layer and then drying the applied color coating agent to form a color coating layer, and applying a clear coating agent onto a surface of the color coating layer and photocuring the applied clear coating agent to form a clear layer. The color coating agent includes 10 to 35% by weight of a modified acrylic resin, 1 to 25% by weight of a pigment, and 40 to 80% by weight of a first solvent. The clear coating agent includes 10 to 30% by weight of a polyester-modified acrylic resin, 5 to 25% by weight of an acrylic oligomer, 5 to 45% by weight of an acrylic monomer, 1 to 15% by weight of a photoinitiator, and 10 to 75% by weight of a second solvent.

Abstract: The present invention relates to a novel formulation comprising a benzimidazole derivative. The formulation for oral administration comprising a compound of Formula 1 according to the present invention or a pharmaceutically acceptable salt thereof; and at least one disintegrant selected from the group consisting of croscarmellose sodium, sodium starch glycolate and low-substituted hydroxypropylcellulose, exhibits an excellent storage stability and has an effect on preventing a phenomenon of decline in dissolution rate, thus being usefully used as a formulation for oral administration.

Abstract: Provided are a message reception notifying method, system, and non-transitory computer-readable recording medium. A message reception notifying method includes predefining a plurality of message types for classifying a message and frames of a notification window for the respective message types; parsing a message received at a user terminal, and determining a type of the received message among the plurality of message types; determining a frame corresponding to the type of the received message among the frames; and creating and providing a notification window for the received message by processing the received message based on the determined frame.

Abstract: The present invention relates to a use of a carbamate compound of formula 1, or a pharmaceutically acceptable salt, solvate or hydrate thereof in the prevention or treatment of diseases associated with an increase in late sodium current.

Abstract: Provided is a method of providing a recommended card, the method including: receiving a radio signal from at least one access point around a device; selecting one from the at least one access point, based on a strength of the received radio signal; determining a card merchant corresponding to the selected access point; determining at least one recommended card regarding the determined card merchant from at least one card registered with the device, based on the card merchant and card benefit information of the registered at least one card; and providing the at least one recommended card.

Abstract: A method for controlling a screen of a mobile terminal that simultaneously displays a plurality of execution screens is provided. The method preferably includes: displaying a layout composed of a plurality of sections when a magazine creation event is sensed; mapping applications to the plurality of sections in a one-to-one correspondence, respectively to create a magazine; and displaying the magazine, and an execution screen of an application mapped to each of the sections is arranged at the magazine.

Abstract: The present invention relates to a food composition comprising Suaeda japonica as an active ingredient for preventing or alleviating diabetes, and to a method for preparing the composition. When Suaeda japonica powder of the present invention is administered to OLETF mice in which obesity and diabetes are naturally induced during growth due to a defect of the CCK-1 gene, an increase in blood glucose and production of glycosylated hemoglobin are inhibited, and the effect of improving glucose tolerance is exhibited. Also, a high blood level of adiponectin, which relates to an improvement in insulin sensitivity and to the recovery of glucose metabolism function, is maintained, and antidiabetic activity, specifically, the effect of alleviating or preventing diabetes, is excellent.

Abstract: A method of providing an augmented reality game environment within a game space includes obtaining, by a processor, sensor data for the game space, determining, by the processor, a position of a player in the game space based on the sensor data, generating, by the processor, player image data of a peripersonal boundary of the player based on the determined position of the player for rendering a representation of the peripersonal boundary in the game space, the peripersonal boundary being disposed about, and spaced from, the determined position, obtaining, by the processor, player data for the player via an input modality, the player data being indicative of a player directive to modulate the peripersonal boundary, adjusting, by the processor, a size of the peripersonal boundary as a function of the player data, and updating, by the processor, the player image data based on the adjusted size of the peripersonal boundary.

Abstract: The present invention relates to use of peptides as a therapeutic agent, wherein it has been confirmed that the peptides of the present invention significantly inhibit the activity of T cells and the differentiation of T helper 17 cells (Th17 cells), which are associated with autoimmune disease, and have remarkable effects of treating and improving arthritis in an animal model of arthritis. Therefore, the peptides may be used as an active ingredient in therapeutic agents for various autoimmune diseases such as bone disease, inflammatory disease or rheumatoid arthritis.

Abstract: The present invention relates to use of peptides as a therapeutic agent, wherein it has been confirmed that the peptides of the present invention significantly inhibit the activity of T cells and the differentiation of T helper 17 cells (Th17 cells), which are associated with autoimmune disease, reduce the secretion of inflammatory cytokine IL-6, and have remarkable effects of treating and improving arthritis in an animal model of arthritis. Therefore, the peptides may be used as an active ingredient in therapeutic agents for various autoimmune diseases such as bone disease, inflammatory disease or rheumatoid arthritis.

Abstract: An image forming method and apparatus, includes setting a processing order of a plurality of operations of a same image data and detailed setup information of the plurality of operations, and executing the plurality of operations using the detailed setup information according to the set processing order.

Abstract: An electronic device is provided. The electronic device includes a touchscreen, at least one processor electrically connected with the touchscreen, and a memory electrically connected with the processor. The memory may store instructions executed to enable the at least one processor to display a first window for running a first application and a second window for running a second application on the touchscreen, display a virtual keypad on a portion of the first window and a portion of the second window corresponding to a first input to a focused window of the first window and the second window, and vary a size of the virtual keypad corresponding to a second input to the virtual keypad.

Abstract: A method of controlling an image forming apparatus is provided. The method includes requesting a remote support service from a terminal or a server connected to the terminal, receiving a request for an access authorization regarding an operation related to the remote support service from the terminal, granting the access authorization to the terminal based on a user input or a pre-set setting, receiving a control command for the remote support service from the terminal, and executing an operation corresponding to the control command according to the access authorization granted to the terminal.

Abstract: Medical imaging device- and display-invariant segmentation and measurement is provided. In various embodiments, a plurality of medical images is read from a data store. Metadata of each of the plurality of medical images is read. The metadata identifies an image acquisition device associated with each of the plurality of medical images. Based on the plurality of medical images and the metadata of each of the plurality of images, a learning system is trained to determine one or more image correction parameters. The one or more image correction parameters optimize segmentation of the plurality of medical images.

Abstract: A method for controlling a screen of a mobile terminal that simultaneously displays a plurality of execution screens is provided. The method preferably includes: displaying a layout composed of a plurality of sections when a magazine creation event is sensed; mapping applications to the plurality of sections in a one-to-one correspondence, respectively to create a magazine; and displaying the magazine, and an execution screen of an application mapped to each of the sections is arranged at the magazine.

Abstract: Disclosed is a game test automation device capable of automating a game test. The 0game test automation device can comprise: a database for storing test procedure information, which is a combination of game scripts to be tested in a game service; and a testing unit for testing game build of the game service on the basis of the test procedure information, and creating game state information derived in the testing process and a test report on the test.

Abstract: A method, system and computer program product for determining changes in breast density. A generative adversarial network is trained to predict an appearance of a mammogram image for a patient's current examination based on mammogram images assigned labels of a first type of density classification. An appearance of a mammogram image for a patient's current examination is predicted using the generative adversarial network based on a mammogram image(s) obtained from the patient's prior examination assigned labels of the first type of density classification. A comparison is made between the predicted and actual mammogram images for the patient's current examination to determine if there is a difference between scores assigned to the predicted and actual mammogram images, and if so, whether such difference can be attributed to the subjective assessment by different physicians or changes in the standards of density classification or is due to a real change in breast density.

Abstract: A medical registration training component executing within a medical registration system performs a training medical registration operation on a pair of medical studies. Responsive to the medical registration training system determining that the training medical registration operation succeeds, the medical registration training system records a medical registration instance for the pair of medical studies in a medical registration history and marks the medical registration instance as a positive instance in the medical registration history. Responsive to the medical registration training system determining that the training medical registration operation requires correction, the medical registration training system records a medical registration instance for the pair of medical studies in the medical registration history and marks the medical registration instance as a negative instance in the medical registration history.